CompletedNot Applicable

Game-Based Intervention to Promote HPV Vaccination

United States133 participantsStarted 2024-04-01

Plain-language summary

This study will examine the feasibility and acceptability of an innovative game-based intervention designed for families of youth aged 11-14 to promote HPV vaccination; will explore changes in key outcomes and related measures; and will identify factors contributing to or impeding effective implementation in health clinic settings. The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in youth via low-cost technology and timely intervention.

Who can participate

Age range

11 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Youth: (1) 11-14 years old; (2) have not received the 1st dose of HPV vaccine; (3) speak and read English * Parent: (1) are the parent/legal guardian of the participating child; (2) ≥ 18 years old; (3) speak English or Spanish; (4) own a smartphone; (5) agree to participate in the research activities at study sites; (6) agree to receive text messages. * Healthcare providers: (1) ≥ 20 years old; (2) speak English or Spanish); (3) work at study sites Exclusion Criteria: * Individuals are unable to comprehend the consent or assent forms due to cognitive issues

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percentage of eligible individuals agreeing to participate

Timeframe: 2 years

Percentage of eligible individuals who complete the intervention (intervention arm only) and assessments (all participants)

Timeframe: 2 years

Ease of use (intervention arm only)

Timeframe: 2 years

Parent and child acceptability of the intervention (intervention arm only)

Timeframe: 2 years

Intention to vaccinate the child against HPV

Timeframe: 2 years

Child vaccination status (1st & 2nd doses).

Timeframe: 2 years

Trial details

NCT IDNCT06162676

SponsorMichigan State University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-30

View on ClinicalTrials.gov More HPV Infection trials

Plain-language summary

Who can participate

Age range

11 Years – 14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Percentage of eligible individuals agreeing to participate

Timeframe: 2 years

Percentage of eligible individuals who complete the intervention (intervention arm only) and assessments (all participants)

Timeframe: 2 years

Ease of use (intervention arm only)

Timeframe: 2 years

Parent and child acceptability of the intervention (intervention arm only)

Timeframe: 2 years

Intention to vaccinate the child against HPV

Timeframe: 2 years

Child vaccination status (1st & 2nd doses).

Timeframe: 2 years